C19 “vaccine” - the cause of causes

13/04/2022

By Coquin de Chien  published 13 Apr 2022 

Massachusetts Data Yields Circulatory Proof

This article is written for all readers, Year 9 students through elder adults. Methods and reasoning herein are pedestrian. Doctors and scientists may opt to skip to "BEGIN HERE TO VIEW DATA". If you really want to cheat, skip to the bottom and look for yellow highlighted cells in spreadsheets. Understand what they represent. They represent significant, proven, excess death in the circulatory system matching what the pharmaceutical companies and governments call "rare", another word seemingly redefined in 2021.

The official Massachusetts database of death certificates contains proof that C19 "vaccines" killed thousands of people in Massachusetts in 2021.

This article details a forensic journey in a one-of-a-kind, brute-force, pedestrian, forensic analysis of the official Massachusetts government data to discover what happened and is happening in a population of ~ 6.9 million people at the fore of C19 "science." Massachusetts is a leading medical and pharmaceutical technology exporter to the world. Some leaders say it is a model for C19 response planning. The truth is that Massachusetts is a model for fraud on the people.

As demonstrated in particularity below, there was a short pandemic of respiratory deaths in 2020. Then, in the year of injections en masse, deaths switched to mainly circulatory system deaths. Something is attacking the circulatory systems of citizens of Massachusetts.

Three main events are initially depicted: a pandemic, an extremely attenuated second wave of disease no longer a pandemic, and a nearly steady-state excess death anomaly in the second half of 2021 (likely began around February 2021, but was obscured by lower than normal deaths of 85+yo's due to culling from C19 in spring 2020).

Investigation of the anomaly indicates that excess deaths are circulatory system involved, also known and documented in the C19 vaccine trial data. Though myocarditis gets the most notoriety, the entire circulatory system is under attack.

Hereinafter, the C19 "vaccine" will be called "gene modification" because it is a more accurate descriptor of the biological injectable product. Industry and government chose "vaccine" because it is more psychologically acceptable to consumers. "Vaccine" has product-class recognition and reputation. Ergo, the definition of "vaccine" was changed in 2020 to accommodate the inclusion of C19 gene modification into this product-class. Lawsuits based on this issue of "definition" are pending.

EUA WARNING

It is an undeniable fact that the Emergency Use Authorization (EUA) for the C19 gene modification circumvented the normal course of years-long clinical trials that ensure safety and effectiveness of oral and injectable biological and pharmaceutical products.

Through the EUA, which granted immunity from tort to the manufacturers, the burden of precautions (clinical trials) was shifted from the least cost avoider (the manufacturer) to the most cost avoider (the consumer). Though the burden of precautions is pecuniary to the manufacturer, it entails loss of life to the consumer. Id est, pharmaceutical manufacturers avoid costs and increase profits, while consumers die or are maimed after assuming the burden of precautions as lab rats.